Athos Capital LTD Moderna, Inc. Transaction History

Athos Capital LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$13.7 - $28.34 $1.57 Million - $3.25 Million	-114,597 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$14.45 - $23.7 $248,120 - $406,952	-17,171 Reduced 13.03%	114,597 $2.33 Million
Q4 2018 Feb 08, 2019	BUY	$13.52 - $18.8 $1.78 Million - $2.48 Million	131,768 New	131,768 $2.01 Million

953

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Athos Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Athos Capital LTD with notifications on news.